Point-of-care testing for patients with diabetes, hyperlipidaemia or coagulation disorders in the general practice setting: A systematic review

Family Practice

Volumn 27, Issue 1, 2009, Pages 17-24

  Gialamas, Angela ^a   St John, Andrew ^b   Laurence, Caroline Olivia ^a   Bubner, Tanya Kaye ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Australian Government Australian Research Council   (Australia)

Author keywords

Anticoagulant therapy; Diabetes; General practice; Hyperlipidaemia; Point of care testing

Indexed keywords

ANTICOAGULANT AGENT; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALBUMIN BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; EDUCATION; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; HYPERLIPIDEMIA; INTERNATIONAL NORMALIZED RATIO; MICROALBUMINURIA; PATIENT MONITORING; PATIENT SATISFACTION; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; PROTHROMBIN TIME; RURAL AREA; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; HOSPITAL INFORMATION SYSTEM; RANDOMIZED CONTROLLED TRIAL; REVIEW;

BLOOD COAGULATION DISORDERS; DIABETES MELLITUS; FAMILY PRACTICE; HUMANS; HYPERLIPIDEMIAS; POINT-OF-CARE SYSTEMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77950473753     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmp084     Document Type: Article

References (14)

1. Price C, St John A. Point-of-Care Testing, 2nd edn. Washington, DC: AACC Press, 2004.
2. Hobbs F, Delaney B, Fitzmaurice D et al. A review of near patient testing in primary care. Health Technol Assess 1997; 1: 1-231.
3. Espicom Healthcare Intelligence. Global Market for Point of Care Diagnostics. Rockville MD: Epsicom, 2007. 07/12/2007, Report No.: ESPI1635947.
4. Laurence C, Gialamas A, Yelland L et al. A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting-rationale, design and baseline characteristics. Trials 2008; 9: 50.
5. Public Health Resource Unit, NHS. Appraisal Tools. 2008. http://www.phru.nhs.uk/Pages/PHD/resources.htm. (accessed on 3 August 2006).
6. Ruffin D, McKenney J. Office-based cholesterol testing: impact on process-of-care in patients with hypercholesterolemia a pilot study. J Pharm Technol 1997; 13: 75-9.
7. Shiach C, Campbell B, Poller L, Keown M, Chauhan N. Reliability of point-of-care prothrombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testing. Br J Haematol 2002; 119: 370-5.
8. Claes N, Buntinx F, Vijgen J et al. The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. Eur Heart J 2005; 26: 2159-65.
9. Claes N, Moeremans K, Buntinx F et al. Estimating the cost-effectiveness of quality-improving interventions in oral anticoagulation management within general practice. Value Health 2006; 9: 369-76.
10. Fitzmaurice D, Hobbs F, Murray E et al. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized controlled trial. Arch Intern Med 2000; 160: 2343-8.
11. Parry D, Fitzmaurice D, Raftery J. Anticoagulation management in primary care: a trial-based economic evaluation. Br J Haematol 2000; 111: 530-3.
12. Khunti K, Stone M, Burden A et al. Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus. Br J Gen Pract 2006; 56: 511-7.
13. Stone M, Burden A, Burden M, Baker R, Khunti K. Near patient testing for glycated haemoglobin in people with type 2 diabetes mellitus managed in primary care: acceptability and satisfaction. Diabet Med 2007; 24: 792-5.
14. Miller C, Barnes C, Phillips L et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 2003; 26: 1158-63.